Straits Times Index
3,339.38 +8.57 (+0.26%) Nikkei
38,577.57 -125.94 (-0.33%) Hang Seng
18,450.43 -26.37 (-0.14%) FTSE 100
8,285.34 +38.39 (+0.47%) Bitcoin USD
70,764.98 -425.23 (-0.60%) CMC Crypto 200
1,476.87 -47.93 (-3.14%)
EW Jan 2026 87.500 put
- Zacks
BD (BDX) Inks Buyout Deal to Expand Smart Connected Care Suite
BD's (BDX) latest agreement is likely to unlock new future value-creation opportunities and expand its portfolio of smart connected care solutions.
- Business Wire
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
NEW YORK, June 05, 2024--Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve patients there were excellent clinical outcomes and valve durability irrespective of the patient’s annulus size or sex. These data were presented during the late-breaking clinical
- Simply Wall St.
Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...
